Search

Titanium has been widely used as a bone implant material due to its high mechanical strength and good biocompatibility. However, implant-related infections and insufficient osteogenic activity can lead to implant failure or delay patient recovery. With this in mind, we fabricated one multifunctional implant coating material, PDA-NOate@CuS. In the as-developed material, CuS, deposited in the outermost layer, not only significantly improved the photothermal properties of polydopamine (PDA), but also released Cu ions to effectively prevent bacterial adhesion. The NO-donor (NOate) under near-infrared irradiation generated NO which strengthened the antibacterial effect of materials. The in vitro antibacterial experiments proved that PDA-NOate@CuS displayed an excellent S. aureus and E. coli inhibitory effect. MC3T3-E1 cell experiment results showed that PDA-NOate@CuS promoted cell adhesion, growth and mineralization. Moreover, the in vivo study demonstrated that a titanium implant coated with Ti@PDA-NOate/CuS markedly enhanced osseointegration and inhibited infection, with good biocompatibility. The present study paves the way for developing novel materials for implant modification, which would benefit the treatment of orthopedic disease. [ABSTRACT FROM AUTHOR]

Context Gestational diabetes mellitus (GDM) is a risk factor for child neurodevelopmental delay. Maternal short sleep duration (SSD) may aggravate glucose metabolism disorder in women with GDM. However, it is unclear whether maternal SSD will further affect the neurodevelopmental outcomes of children. Objective To identify the association of GDM complicated with SSD and child neurodevelopmental delay. Methods This prospective study included 7069 mother-child pairs. Between 24 and 28 weeks of gestation, GDM was based on the 75-g oral-glucose-tolerance test. Self-reported sleep duration was collected via the Pittsburgh Sleep Quality Index questionnaire in the second (24-28 weeks) and third (32-36 weeks) trimesters. Outcomes of neurodevelopmental delay in 6 to 36 months postpartum were evaluated using Denver Developmental Screening Test-II and Gesell Development Diagnosis Scale. Results Compared with the unexposed group, women with "GDM + SSD" have the greatest risks of child neurodevelopmental delay (hazard ratio with 95% CI: 1.58 [1.03-2.44]). "GDM + SSD" was associated with the greatest risks of maternal-fetal glucose metabolic disorder. An interquartile ratio (0.58 mmol/L) increase in cord blood C-peptide was associated with the risk of child neurodevelopmental delay (hazard ratio with 95% CI: 1.28 [1.12-1.48]). The stronger linear association of maternal glucose metabolism profiles and C-peptide in women with "GDM + SSD" was also demonstrated. The proportion of association between "GDM + SSD" and child neurodevelopmental delay mediated by C-peptide was 14.4%. Conclusion GDM complicated with SSD was associated with increased risk for child neurodevelopmental delay by enhancing the intergenerational association of maternal-fetal glucose metabolism disorder. [ABSTRACT FROM AUTHOR]